Meyer Vitabiotics’ Research Shows Potential of Antioxidants in Treating Male Infertility
Meyer Vitabiotics, a subsidiary of Vitabiotics Ltd, has conducted a study demonstrating the potential of antioxidant micronutrients and vitamins in improving male fertility. The research involved 300 Indian males with varying types and degrees of infertility and tested the effectiveness of Oligocare Forte Plus, a supplement containing a mix of multi-vitamins, minerals, essential amino acids, ginseng, and lycopene. Results revealed a 75.76% increase in sperm count among males with a baseline sperm count of less than 5 million/ml.
Male infertility is a significant global concern, responsible for 20-30% of total cases. Existing treatment options, such as surgery, hormonal therapy, and drug therapy, are often costly, uncertain in their effectiveness, and come with potential side effects. Antioxidants have gained increasing interest among clinicians and researchers for boosting parameters of male fertility.
The study aimed to evaluate the safety, efficacy, and tolerability of Oligocare Forte Plus, with results showing promising outcomes for male infertility treatment. The trial focused on the efficacy of antioxidant therapy for male infertility, with a specific focus on improving semen parameters and the DNA Fragmentation Index (DFI). The Oligocare Forte Plus tablet, also known as Wellman Conception in the UK, combines essential micronutrients, amino acids, antioxidants, and vitamins crucial for male reproductive health. Antioxidants frequently prescribed for treating male infertility include vitamins E and C, carnitine, N-acetyl cysteine, selenium, and zinc.
Meyer Vitabiotics’ study offers new insights into male infertility treatment, showcasing the potential of antioxidant micronutrient therapy as a more accessible, cost-effective, and clinically efficient alternative to traditional treatment options. The results provide valuable insights into the impact of antioxidant therapy on improving semen parameters and the DNA Fragmentation Index (DFI), highlighting the potential of multi-micronutrient therapy for addressing male infertility. The study provides a much-needed perspective on male infertility treatment, providing hope for millions of men worldwide who suffer from male factor infertility.